FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Sovaldi (sofosbuvir) from Gilead Sciences, Inc. The approval updates the product’s labeling/indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Sovaldi (Sofosbuvir)

Snippet

SUPPL AP for SOVALDI (SOFOSBUVIR)